MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 422 filers reported holding MEDIVATION INC in Q2 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $217,000 | +361.7% | 3,597 | +252.6% | 0.00% | – |
| Q1 2016 | $47,000 | +4600.0% | 1,020 | +5000.0% | 0.00% | – |
| Q4 2015 | $1,000 | -50.0% | 20 | -52.4% | 0.00% | – |
| Q3 2015 | $2,000 | -60.0% | 42 | -10.6% | 0.00% | – |
| Q2 2015 | $5,000 | +400.0% | 47 | +327.3% | 0.00% | – |
| Q1 2015 | $1,000 | -96.0% | 11 | -95.8% | 0.00% | – |
| Q4 2014 | $25,000 | -46.8% | 261 | -45.5% | 0.00% | – |
| Q3 2014 | $47,000 | +104.3% | 479 | +57.6% | 0.00% | – |
| Q2 2014 | $23,000 | -46.5% | 304 | -55.4% | 0.00% | – |
| Q1 2014 | $43,000 | -73.5% | 682 | -73.0% | 0.00% | – |
| Q4 2013 | $162,000 | +194.5% | 2,528 | +175.4% | 0.00% | – |
| Q3 2013 | $55,000 | -82.6% | 918 | -85.7% | 0.00% | – |
| Q2 2013 | $316,000 | – | 6,433 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $158,535,000 | 79.84% |
| Cormorant Asset Management, LP | 546,900 | $34,903,000 | 10.13% |
| BB BIOTECH AG | 1,479,706 | $94,435,000 | 5.04% |
| PFM Health Sciences, LP | 2,719,859 | $173,581,000 | 3.49% |
| Partner Investment Management, L.P. | 219,981 | $14,039,000 | 3.19% |
| Orbimed Advisors | 3,123,500 | $199,342,000 | 2.93% |
| Antipodean Advisors LLC | 525,000 | $33,506,000 | 2.90% |
| Eventide Asset Management | 134,800 | $8,603,000 | 2.65% |
| Bain Capital Public Equity Management, LLC | 1,428,117 | $91,142,000 | 2.58% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 257,055 | $16,405,000 | 2.52% |